Company: IXHL
Filing Date: 2025-05-16
Form Type: DEFA14A
Source: 0001213900-25-044454
Chunk: 5

Company: Incannex Healthcare Inc.
Filing Date: 2025-05-16
Form: DEFA14A
Chunk 5
---
700
Warrant Shares, if the Company were to pay to the Warrant Holders an aggregate of approximately $12.5 million in Net Proceeds as described
above.

The
Warrant Holders also waived certain reserve requirements to permit the Company to reserve shares of its common stock for issuance pursuant
to the Sales Agreement completed prior to receipt of the Stockholder Approval and, until the Company’s receipt of the Stockholder
Approval, waived provisions of the Securities Purchase Agreement that prohibited sales pursuant to the Sales Agreement at a price less
than $1.08 per share.

<div align='center'>1</div>

The
Company is not obligated to issue or sell any of its common stock under the Sales Agreement and there is no assurance that it will choose
to or be able to issue or sell its common stock under the Sales Agreement for a significant amount of Net Proceeds, if any. In addition,
while the Company’s special meeting to consider the Stockholder Approval is scheduled for May 27, 2025, there can be no assurance
that the Stockholder Approval will be obtained at this special meeting or otherwise.

The
foregoing description of the Letter Agreements is not complete and is qualified in its entirety by reference to the full text of the Letter
Agreements, a copy of which is attached hereto as Exhibit 1.1, and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

| Exhibit No. |     | Description                                                                 |
| 1.1         |     | Form of Letter Agreement.                                                   |
| 104         |     | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

<div align='center'>2

SIGNATURES</div>

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

| Date: May 15, 2025 | Incannex Healthcare Inc. 
 /s/ Joel Latham          |                                       |
|:-------------------|:-------------------------|:--------------------------------------|
|                    | Name:                    | Joel Latham                           |
|                    | Title:                   | Chief Executive Officer and President |

<div align='center'>3</div>

Exhibit 1.1

May 15, 2025

Incannex Healthcare Inc.

8 Century Circuit, Suite 105 Norwest

Sydney, NSW